| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/18/2001 | CN1291981A Thiophene nitrone compounds |
| 04/18/2001 | CN1291980A thioether furan nitrone compounds |
| 04/18/2001 | CN1291979A Novel pyridazine derivatives and drugs containing same as active ingredient |
| 04/18/2001 | CN1291899A Live recombined vaccines injected with adjuvant |
| 04/18/2001 | CN1291609A Method of preparing 5-lipoxidase inhibitor possessing different heterocyclic ring system |
| 04/17/2001 | US6218430 Vitamin D3 mimics |
| 04/17/2001 | US6218424 Heterocyclic ketone and thioester compounds and uses |
| 04/17/2001 | US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal |
| 04/17/2001 | US6218419 Aminoiminoquinone and aminoquinone alkaloid compounds and methods of use |
| 04/17/2001 | US6218418 Therapy of cell proliferative disorders associated with an altered cell dependent kinase activity by administering amino pyrazole derivative to mammal |
| 04/17/2001 | US6218397 For therapy of stress-related illnesses, such as stress-induced depression, anxiety, and headache; abdominal bowel syndrome; inflammatory diseases; immune suppression; alzheimer's disease; gastronintestinal diseases |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218376 For treating inflammatory diseases |
| 04/17/2001 | US6218371 Administering immunopotentiating cytokine selected from group consisting of gm-csf, il-2, il-4 and ifn-.gamma., and immunostimulatory cpg oligonucleotide for inducing synergistic antigen specific immune response |
| 04/17/2001 | US6218359 Treating autoimmune, arthritic, tumor diseases |
| 04/17/2001 | US6218165 Protease with altered t-cell epitopes; prevents sensitization of individual to protein; detergents; treatment of wool to prevent felting; soaps; cosmetics; skin care |
| 04/17/2001 | US6218148 DNS encoding stem cell factor |
| 04/17/2001 | US6218133 Materials and methods for detection and treatment of immune system dysfunctions |
| 04/17/2001 | US6218132 Activating t-cells with antigen to cause expansion, reactivating with antigen and antigen presenting cells to induce secretion of soluble factor, then detecting by capturing factor on solid support |
| 04/17/2001 | US6218113 Human protein kinase C inhibitor |
| 04/17/2001 | US6217883 Immunology response |
| 04/17/2001 | US6217877 Extraction using water miscible solvent |
| 04/17/2001 | US6217875 Inhibitors of lipoxygenase |
| 04/17/2001 | US6217873 Polyoxime compounds and their preparation |
| 04/17/2001 | CA2196054C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
| 04/13/2001 | CA2321260A1 Oral immunology using plant product containing hepatitis surface antigen |
| 04/13/2001 | CA2320741A1 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/13/2001 | CA2320518A1 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/12/2001 | WO2001025793A2 Diagnosis of coeliac disease using a gliadin epitope |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025450A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 04/12/2001 | WO2001025442A1 Dna polymerase lambda and uses thereof |
| 04/12/2001 | WO2001025438A2 Ifn-alpha homologues |
| 04/12/2001 | WO2001025437A2 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | WO2001025415A2 Gene transfer in human lymphocytes using retroviral scfv cell targeting |
| 04/12/2001 | WO2001025405A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 04/12/2001 | WO2001025398A2 Process for inducing functional tolerance to gene transfer products |
| 04/12/2001 | WO2001025282A1 Il13 mutants |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025242A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 04/12/2001 | WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 04/12/2001 | WO2001025218A1 Novel quinazoline derivatives |
| 04/12/2001 | WO2001025209A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/12/2001 | WO2001025208A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024824A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/12/2001 | WO2001024823A1 Cd40 antagonist for treating psoriasis |
| 04/12/2001 | WO2001024822A2 Pharmaceutical composition comprising an antigen |
| 04/12/2001 | WO2001024818A1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific t cell responses |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024814A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/12/2001 | WO2001024810A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | WO2001024787A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO2001024763A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | WO2001024627A1 Animal with the mass expression of human gene and test method by using the animal |
| 04/12/2001 | WO2001005420A8 SMALL PEPTIDES AND METHODS FOR DOWNREGULATION OF IgE |
| 04/12/2001 | WO2000069426A3 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
| 04/12/2001 | WO2000064938A3 Peptide homodimers or peptide heterodimers derived from interleukin 12 |
| 04/12/2001 | WO2000064458A3 Method for inducing a donor tolerance in the human body |
| 04/12/2001 | WO2000056304A3 Anti-inflammatory uses of manzamines |
| 04/12/2001 | CA2699662A1 Rhodamine derivatives for photodynamic diagnosis, prevention and treatment of immunologic disorders |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2388785A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 04/12/2001 | CA2388229A1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific t cell responses |
| 04/12/2001 | CA2388227A1 A human gene over-expressing animal and test methods using the animal |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386533A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 04/12/2001 | CA2386499A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386248A1 Il13 mutants |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386228A1 Stabilized liquid pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) polypeptides |
| 04/12/2001 | CA2386192A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 04/12/2001 | CA2386163A1 Novel quinazoline derivatives |
| 04/12/2001 | CA2386089A1 Diagnostic and therapeutic epitope and transgenic plant |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385528A1 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | CA2385045A1 Ifn-alpha homologues |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090639A2 Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator |
| 04/11/2001 | EP1090637A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/11/2001 | EP1090130A1 Protein c derivatives |
| 04/11/2001 | EP1090122A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 04/11/2001 | EP1090104A1 Methods of expanding and selecting disease associated t-cells |
| 04/11/2001 | EP1090039A1 Peptide composition as immunogen for the treatment of allergy |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | EP1089963A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 04/11/2001 | EP1089761A2 Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies |
| 04/11/2001 | EP1089758A1 Mucosal targeting immunisation |
| 04/11/2001 | EP1089757A1 Hla binding peptides and their uses |
| 04/11/2001 | EP1089752A1 Alpha-keto oxadiazoles as serine protease inhibitors |